FIELD: medicine.
SUBSTANCE: present invention concerns medicine, specifically a powder delivery system containing a composition which contains a gelatinous or collagen powder with minimal average particle size 10 mcm. Usually, said gelatinous or collagen powder are presented in dry form, i.e. no liquid components and/or propellants are added to the composition. Besides the invention refers to the advanced powder delivery system which contains a protective structure, such as edge enclosure nearby a hole of the delivery system. The invention refers to the gelatine or collagen compositions used for haemostasis, and also to the powder delivery system including the ready-to-use gelatinous or collagen powder in the dry form. Additionally, the powder delivery system can contain a dry agent incompatible with humidity and/or water.
EFFECT: invention provides fast and more effective haemostasis.
34 cl, 10 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HEMOSTATIC COMPOSITION COMPRISING HYALURONIC ACID | 2005 |
|
RU2369408C2 |
| HAEMOSTATIC COMPOSITION CONTAINING HYALURONIC ACID | 2009 |
|
RU2486921C2 |
| TRANEXAMIC ACID SPRAY FOR KNEE JOINT ARTHROPLASTY | 2018 |
|
RU2739771C1 |
| HAEMOSTATIC SPONGE | 2011 |
|
RU2562569C2 |
| TISSUE-ADHESIVE POROUS HAEMOSTATIC PRODUCT | 2015 |
|
RU2704259C2 |
| FAST-ACTING SEALING AND THE METHODS OF ITS APPLICATION AND PRODUCTION | 2007 |
|
RU2442612C2 |
| HEMOSTATIC COMPOSITIONS AND METHODS FOR THEIR PREPARATION | 2017 |
|
RU2756891C2 |
| COLLAGEN POWDER AND COLLAGEN-BASED THERMOPLASTIC COMPOSITION FOR MOULDING ARTICLES | 2006 |
|
RU2406732C2 |
| HAEMOSTATIC POWDER | 2020 |
|
RU2820476C2 |
| DRY COMPOSITION FOR USE IN HAEMOSTASIS AND WOUND HEALING | 2015 |
|
RU2715235C2 |
